1-2 of 2
Steven Novick, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Nilotinib in Imatinib-Resistant or -Intolerant Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP): 48-Month Follow-up Results of a Phase 2 Study,

Philipp D. le Coutre, MD, Francis J. Giles, MB, MD, FRCPI, FRCPath, Javier Pinilla-Ibarz, MD, PhD, Richard A. Larson, MD, Norbert Gattermann, MD, Oliver G. Ottmann, MD, PhD, Andreas Hochhaus, MD, Jerald P. Radich, MD, Giuseppe Saglio, MD, Timothy P. Hughes, MD, MBBS, Giovanni Martinelli, MD, Dong-Wook Kim, MD, PhD, Susan Branford, PhD, Martin C. Müller, MD, Yaping Shou, MD, PhD, Steven Novick, MD, PhD, Xiaolin Fan, PhD, Jorge E. Cortes, Michele Baccarani, MD, Hagop M. Kantarjian
Journal: Blood
Blood (2011) 118 (21): 3770.
https://doi.org/10.1182/blood.V118.21.3770.3770
Published: 2011
Journal Articles

5-Year Follow-up of Patients with Relapsed/Refractory CLL Treated with Standard Chemotherapy with or without Oblimersen in Randomized Phase III Trial: Prognostic Factors and Predictive Factors for Treatment Effect

Susan O’Brien, M.D., Jane Wu, PhD, Steven Novick, MD, PhD, Kanti R. Rai, MD
Journal: Blood
Blood (2008) 112 (11): 4201.
https://doi.org/10.1182/blood.V112.11.4201.4201
Published: 2008